glp 1 receptor agonists weight loss What Are GLP-1 For Loss? GLP-1 Receptor Agonists as Treatments

Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified

Short-term use of adjunct medications like proton pump inhibitors and H2-antagonists for reflux, or cyclizine for nausea, can be beneficial

doi:10.2337/db08-1101 98

The dual mechanism is designed to mimic the complementary metabolic effects of diet and exercise: GLP-1 receptor activation reduces appetite and enhances insulin secretion, while glucagon receptor activation increases energy expenditure and promotes hepatic fat oxidation

While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy